Robin Low, CEO & Founder of Areteon, Singapore

Case study: Areteon, Singaporean company working to solve the global AMR problem

Emily Event News Leave a Comment

Drug-resistant microbial is one of the hottest topics of the 21st century. With the potential to cause nearly $100 trillion in damage to the world’s health and economy, the issue of infections untreatable by modern antibiotics is one that leaves many concerned and looking for solutions. But did you know a Singapore-based biotech company is part of effort to prevent …

Pictured Erick Co, CSO of Formosa Pharmaceutical during the acquisition of Activus Pharma, August 2017.

Expanding from a pure API provider to new drug developer: Formosa is growing

Emily Event News Leave a Comment

Pictured Erick Co, CSO of Formosa Pharmaceutical during the acquisition of Activus Pharma, August 2017.  Formosa Pharma, Taiwan is a subsidiary of globally-recognized API provider, Formosa Laboratories. This preclinical and clinical stage biopharmaceutical company has a strong focus on anti-infective and oncology indications. Having recently acquired Activus Pharma and its Activus Pure Nanoparticle Technology Platform (APNT), Formosa Pharmaceuticals is growing …

Marc Voigt, CEO of Immutep (Previously Prima Biomed) speaking at Phar-East 2018, Singapore, 28Feb-2Mar

10 minutes with Marc Voigt, CEO of Immutep (Previously known as Prima Biomed)

Emily Event News Leave a Comment

Prima Biomed was originally built on CVac, a therapeutic cancer vaccine. With its recent shift to embrace multiple products, the company has decided to rebrand itself to Immutep, named after a subsidy acquired in 2014. Leading the company is Marc Voigt, who will join us at Phar-East 2018 to speak about their vision of the next big immune checkpoint in the immunotherapy race. …

Bandana Sharan APAC biotech

India’s first dendritic cell therapy company: APAC Biotech

Emily Event News Leave a Comment

If you have worked in India’s pharma industry, you’ll probably have heard about APAC Biotech before this article. The company is the first in India to work on this new exciting branch of cancer therapeutics: Dendritic Cell Therapy. They conducted the first trial in India on Autologous Dendritic Cell Immunotherapy for Refractory Cancer Treatment and were the first to receive …

CSIRO (Denis & Oscar)

Bioinformatics from patient recruitment, disease modeling to preventive healthcare

Emily Event News Leave a Comment

The Commonwealth Science and Industrial Research Organisation (CSIRO) has advanced Australia with a range of inventions and innovations that have had a significant positive impact on the lives of people around the world. Among the various units in CSIRO, the Health and Biosecurity business unit is committed to advancing public health and protecting biosecurity by improving the safety, quality and …

top 8 immunotherapy companies

CStone, OBI, Tessa Therapeutics & more join other immunotherapy leaders at Phar-East 2018

Emily Event News Leave a Comment

In case you missed our email last week, we shared 8 fantastic immunotherapy experts confirmed to speak at Phar-East 2018, Singapore, taking place 28th February to 2nd March. Speaking on their latest work, these distinguished speakers from Asia pharma industry will share their experience, lessons learnt and future plans. First of all, we have Frank Jiang, CEO and founder of CStone. Recently …

Frank Jiang, Founder and CEO speaking at Phar-East 2018, Singapore, 28February-2 March 2018

5 minutes with Frank Jiang, founder of CStone, a Chinese immunotherapy biotech company

Emily Event News Leave a Comment

Immunotherapy advancement is a global trend, but it’s also greatly impacting the future of pharma in Asia. To prepare for this week’s feature, we interviewed Dr Frank Jiang, CEO and founder of CStone, a Chinese biotech company focused on addressing the most important patient needs in China and beyond. With immuno-oncology as CStone’s core therapeutic focus, the company strives to lead Chinese …

Yuliana Indriati, President Director of PT Kalbe Genexine Biologics is speaking at Phar-East 2018

PT Kalbe Genexine Biologics on Indonesia biologics landscape

Emily Event News Leave a Comment

As you know, PT Kalbe Farma Tbk (“Kalbe”) was established in 1966 and headquartered in Jakarta. It is the largest, publicly listed pharmaceuticals company in Southeast Asia with over US$6 billion in market capitalization and revenues of over IDR 7 trillion (2016). Partnering with Genexine, Inc (KOSDAQ, 095700), another listed company of 20 years history, specialising in clinical stage biotechnology with a focus on …

PGT speaking at Phar-East 2018, Singapore

Biotech Highlight: Pacific Gene Tech (PGT)

Emily Event News Leave a Comment

Pacific Gene Tech (PGT) is an Asian vaccine company developing and commercialising first and/or best-in-class vaccines for areas of high unmet or under-served needs in food safety and livestock animal health. While working on livestock diseases, they discovered that one of their proprietary platforms has broad cross-protection for both human and livestock industries. Led by an experienced management team and advised …

Malini Raj, Australian Pituitary Foundation and World Alliance of Pituitary Organisations

Empowered patients’ roles in drug development

Emily Event News Leave a Comment

Patients are the focus of the healthcare ecosystem. More than ever before, in this digital age, patients are empowered with knowledge of available treatments, as well as the shorter reach to get their voice to providers and regulators. At Phar-East 2018, we bring together the entire JAPAC pharma ecosystem to discuss the most important trends impacting the healthcare& pharma industry …